EVP, Global Head of Research and Development · Atara Biotherapeutics, Inc. (ATRA)

Jakob Dupont

A named executive officer of Atara Biotherapeutics in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$2,728,269

Salary $519,231Stock awards $921,600Bonus $130,000

FY2020: $2,796,245

2nd of 5 named executive officers at Atara Biotherapeutics by FY2021 total.

5 named officers on file for Atara Biotherapeutics, FY2021

Jakob Dupont’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • ATRA’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Atara Biotherapeutics’s whole pay program stands against its peers

  • Atara Biotherapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ATRA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2022 (DEF 14A).

Free

Get Jakob Dupont’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Jakob Dupont compensation by year

Atara Biotherapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Atara Biotherapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$319,231$519,231
Bonus$130,000$130,000
Stock awards$443,075$921,600
Option awards$1,757,296$921,622
Non-equity incentive$143,346$227,963
Pension and deferred compensation$0$0
All other$3,297$7,853
Total$2,796,245$2,728,269

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Atara Biotherapeutics, Inc. DEF 14A filed April 27, 2022, accession 0001564590-22-016087, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Atara Biotherapeutics, Inc. filed document, accession 0001564590-22-016087. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2022.

$2.8M
$2.7M
FY20
FY21
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU46,250$907,888—

Per the Outstanding Equity Awards at Fiscal Year-End table in Atara Biotherapeutics, Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Atara Biotherapeutics’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Pascal TouchonPresident & Chief Executive Officer$5,117,335
Jakob Dupont · this pageEVP, Global Head of Research and Development$2,728,269
Utpal KoppikarChief Financial Officer$2,224,682
Amar MuruganSVP, General Counsel$2,040,252
Kristin YaremaSVP, Chief Commercial Officer$1,889,494

The full Atara Biotherapeutics compensation record

free company brief

This page is one person within Atara Biotherapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Atara Biotherapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Atara Biotherapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jakob Dupont's compensation dossier · One-time report. No refunds.